Delivery Order SPE2DB24D2212-SPE2DB25FHNTN
Award Date
1/16/25
Potential Completion Date
1/17/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $11,087.40 and covers the delivery of 4,567,118,623 units of Olmesartan Medoxomil 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a $6,007.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Olmesartan Medoxomil 40 mg tablets in 90-count packages. The contract has a period of performance through February 4, 2025 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Olmesartan Medoxomil 40 mg tablets. The contract is a Delivery Order valued at $5,181.98 and has a firm fixed price pricing structure. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,439.49 firm fixed-price delivery order contract is for the supply of Olmesartan Medoxomil 40 mg tablets. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,242.12, is for the delivery of Olmesartan Medoxomil 40 mg tablets. This is a firm fixed-price delivery order contract with a completion date of September 26, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a broader $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,738.39 firm fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication, valued at $2,372.08. The contract has an ultimate completion date of October 18, 2023 and is a firm fixed-price delivery order. The contract is not designated with a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,916.97, is a Firm Fixed Price Delivery Order for the provision of Olmesartan Medoxomil 40 mg tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,453.89 fixed-price delivery order is for the supply of 4,562,817,379 units of the drug Olmesartan Medoxomil 40 mg tablets, with a completion date of November 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $8,942.01 with a firm fixed price for the delivery of Olmesartan Medoxomil 40 MG Tablets. The contract has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...